Jeffrey Hyams, MD
Division Head, Gastroenterology
Director, The Inflammatory Bowel Disease Center
Director, The Infusion Center
Mandell-Braunstein Family Endowed Chair for Pediatric Inflammatory Bowel Disease
Meet Jeffrey Hyams, MD
BA, Brandeis University, 1971
MD, University of Pennsylvania School of Medicine, 1975
Pediatrics, Boston Children’s Hospital, 1975-1978
Medicine and Gastroenterology, Boston Children’s Hospital, 1978-1980
Professor of Pediatrics, University of Connecticut School of Medicine
Dr. Hyams is one of the world’s leading experts in pediatric inflammatory bowel disease (IBD) including Crohn’s disease and ulcerative colitis. He has led pivotal clinical trials of biological agents in these disorders and has directed a long-term natural history registry that has described the course of almost 2000 children newly diagnosed with IBD. Dr. Hyams is the recent recipient of a $10.4M grant from the National Institutes of Health investigating the response of children newly diagnosed with ulcerative colitis to standardized therapies. He has worked with the FDA developing endpoints for pediatric clinical trials, and serves on the Rome Committee, an international research organization that investigates the course and treatment of functional GI disorders such as irritable bowel syndrome, functional abdominal pain, abdominal migraine and functional dyspepsia.
Dr. Hyams has published more than 250 peer reviewed articles, and is the co-editor of one of the standard pediatric digestive disease textbooks, Pediatric Gastrointestinal and Liver Disease, now in its 5th edition. He has also published numerous chapters and monographs on pediatric gastrointestinal disorders. View Dr. Hyams’ ResearchGate profile.